Retatrutide works as a powerful triple-agonist, meaning it works on on three key hormone receptors: The human glucagon receptor (GCGR) The glucose-dependent insulinotropic polypeptide receptor (GIP) The glucagon-like peptide-1 receptor (GLP-1) This unique receptor profile allows retatrutide to effectively: Regulate appetite, feelings of fullness, and gastric emptying Regulate metabolism Regulate blood sugar levels Retatrutide activates the GIP, GLP-1, and GCG receptors simultaneously, leading to better weight loss and cardiometabolic benefits compared to targeting a single receptor
Clinical data shows a clear dose-response relationship, with higher doses producing significantly greater weight loss
This suggests that individuals with a higher BMI may need more supplemental vitamin D than leaner individuals and is consistent with previous evidence indicating that obesity may impair formation of active vitamin D
The exact mechanisms underlying leptin resistance remain under investigation, but chronic inflammation, endoplasmic reticulum stress, and disrupted leptin transport across the blood-brain barrier are thought to contribute
and Schifano, F
Accessed 15 Oct 2018